These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6147902)

  • 1. Pharmacologic investigation of compounds related to 3,4-methylenedioxyamphetamine (MDA).
    Davis WM; Borne RF
    Subst Alcohol Actions Misuse; 1984; 5(2):105-10. PubMed ID: 6147902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of catecholaminergic receptor blockers with lethal doses of amphetamine or substituted amphetamines in mice.
    Davis WM; Hatoum HT; Waters IW
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):27-36. PubMed ID: 687391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevance to hazards of MDMA (Ecstasy) abuse.
    Davis WM; Hatoum HT; Waters IW
    Alcohol Drug Res; 1987; 7(3):123-34. PubMed ID: 2881551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, identification, and acute toxicity of some N-alkyl derivatives of 3,4-methylenedioxyamphetamine.
    Noggle FT; DeRuiter J; Coker ST; Clark CR
    J Assoc Off Anal Chem; 1987; 70(6):981-6. PubMed ID: 3436914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triphasic dose-lethality relationships for amphetamine and certain ring-substituted amphetamines in isolated or aggregated mice.
    Davis WM; Waters IW; Hatoum HT; Buelke JL; Braude MC
    Res Commun Chem Pathol Pharmacol; 1977 Aug; 17(4):575-82. PubMed ID: 578333
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of brain interactions with methylenedioxyamphetamine and methylenedioxymethamphetamine.
    Zaczek R; Hurt S; Culp S; De Souza EB
    NIDA Res Monogr; 1989; 94():223-39. PubMed ID: 2575226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research on the central activity and analgesia of N-substituted analogs of the amphetamine derivative 3,4-methylenedioxyphenylisopropylamine].
    Braun U; Shulgin AT; Braun G
    Arzneimittelforschung; 1980; 30(5):825-30. PubMed ID: 7190428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and long-term neurochemical effects of methylenedioxymethamphetamine in the rat.
    Schmidt CJ
    NIDA Res Monogr; 1989; 94():179-95. PubMed ID: 2575224
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of cardiovascular, hyperthermic, and toxic effects of para-methoxyamphetamine (PMA) and 3, 4-methylenedioxyamphetamine (MDA).
    Nichols DE; Ilhan M; Long JP
    Arch Int Pharmacodyn Ther; 1975 Mar; 214(1):133-40. PubMed ID: 1174022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of anesthesia and phenoxybenzamine on responses of dogs to IV subtoxic doses of 3,4-methylenedioxyamphetamine (MDA).
    Waters IW; Catravas JD; Davis WM
    Arch Int Pharmacodyn Ther; 1986 Jun; 281(2):240-51. PubMed ID: 3753103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrophotometric and liquid chromatographic identification of 3,4-methylenedioxyphenylisopropylamine and its N-methyl and N-ethyl homologs.
    Noggle FT; DeRuiter J; Long MJ
    J Assoc Off Anal Chem; 1986; 69(4):681-6. PubMed ID: 2875058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective effects of methysergide, 6-hydroxydopamine and other agents on the toxicity of amphetamine, phentermine, MDA, PMA, and STP in mice.
    Lopatka JE; Brewerton CN; Brooks DS; Cook DA; Paton DM
    Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):677-87. PubMed ID: 989173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of MDMA-like substances.
    Nichols DE; Oberlender R
    NIDA Res Monogr; 1989; 94():1-29. PubMed ID: 2575223
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats.
    Gold LH; Koob GF; Geyer MA
    J Pharmacol Exp Ther; 1988 Nov; 247(2):547-55. PubMed ID: 2903234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjunction with diazepam.
    Gasior M; Carter RB; Goldberg SR; Witkin JM
    J Pharmacol Exp Ther; 1997 Aug; 282(2):543-53. PubMed ID: 9262314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Ecstasy': a human neurotoxin?
    Peroutka SJ
    Arch Gen Psychiatry; 1989 Feb; 46(2):191. PubMed ID: 2563326
    [No Abstract]   [Full Text] [Related]  

  • 18. Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals.
    Ricaurte G; Bryan G; Strauss L; Seiden L; Schuster C
    Science; 1985 Sep; 229(4717):986-8. PubMed ID: 4023719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an i.v. lethal dose of 3,4-methylenedioxyamphetamine (MDA) in the dog and antagonism by chlorpromazine.
    Davis WM; Catravas JD; Waters IW
    Gen Pharmacol; 1986; 17(2):179-83. PubMed ID: 3699443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.